Philippe Laffont’s Guardant Health GH Stock Holding History

Philippe Laffont’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-261,603	Closed	-$26.2M	–	71
2021 Q4	$26.2M	Sell	261,603 -2,543,670	-91%	-$263M	0.12%	55
2021 Q3	$351M	Buy	2,805,273 +144,070	+5%	+$17.1M	1.43%	27
2021 Q2	$330M	Buy	2,661,203 +642,750	+32%	+$86.5M	1.28%	27
2021 Q1	$308M	Buy	2,018,453 +899,916	+80%	+$136M	1.69%	20
2020 Q4	$144M	Hold	1,118,537	–	–	0.54%	38
2020 Q3	$125M	Sell	1,118,537 -456,440	-29%	-$41.8M	0.66%	32
2020 Q2	$128M	Sell	1,574,977 -717,250	-31%	-$57.8M	1.12%	26
2020 Q1	$160M	Buy	2,292,227 +340,347	+17%	+$26.1M	2.02%	21
2019 Q4	$153M	Buy	1,951,880 +1,158,897	+146%	+$83.5M	1.21%	27
2019 Q3	$50.6M	Sell	792,983 -403,013	-34%	-$35.5M	0.43%	36
2019 Q2	$103M	Buy	+1,195,996	New	+$91.3M	0.87%	28

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Philippe Laffont's GH Position: Q1 2022 in Review

Philippe Laffont sold out of Guardant Health (GH) in Q1 2022, closing a stake of 261,603 shares — an estimated $26.2M sold.

Philippe Laffont first reported a position in GH in Q2 2019 and held it in 11 quarters. The position peaked at $351M in Q3 2021. 355 funds tracked by Wall St. Rank hold GH as of Q1 2022.

Philippe Laffont reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
Philippe Laffont sold 261,603 Guardant Health shares in Q1 2022, an estimated $26.2M.
Philippe Laffont first reported a position in Guardant Health in Q2 2019 and held it in 11 quarters.
Philippe Laffont's Guardant Health position peaked at $351M in Q3 2021.
355 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Coatue Management's 13F filing for Q1 2022, filed 16 May 2022.